Suboxone Taper Consulting

For the taper that has a plan but keeps losing ground.

You already know the framework. Stabilize first. Reduce slowly. Protect sleep. Don't push through instability.

What you don't have is a read on your specific pattern — where the instability is actually coming from, what's making the reductions collapse at the same threshold every time, and what the correct sequence looks like from where you are right now.

That's what a Plan Review is.

Why the Same Taper Fails at the Same Place

Buprenorphine's 37-hour half-life is what makes it clinically useful for stabilization. It's also what makes the taper deceptive.

You reduce the dose. The body doesn't register the full change for 48 hours. You feel stable on day one and two. Then on day three or four, sleep starts to fragment — waking at 3 AM, restlessness, shallow hours that leave you running on empty by afternoon. Anxiety edges up. The dose you reduced to no longer feels like enough.

Most people at this point either hold longer than necessary, push forward into real instability, or quietly return to the previous dose to stop the bleeding.

None of those outcomes advance the taper.

Sleep continuity is where this shows up first — before cravings intensify, before anxiety becomes unmanageable. It's the earliest signal that the reduction moved faster than the nervous system could track. When sleep breaks, the next reduction isn't the right move. Identifying what needs to stabilize first — and what that stabilization actually looks like — is the question the Plan Review answers.

What a Plan Review Is

A 60-minute structured session built around your specific pattern. Not a generic taper schedule. Your current dose, your reduction history, the specific places it has stalled, the sleep picture, the instability signals that keep appearing.

Before the call you complete a VDI intake assessment — five domains, scored. The results reach me before we talk. The call starts informed.

Within 48 hours you receive a written deliverable. Five sections:

Pattern Assessment — where you sit on the VDI spectrum, what the instability signals indicate, what the pattern looks like structurally.

Barrier Identification — what has specifically prevented successful reduction in your history. Not generic barriers. Yours.

Sequencing Recommendation — what needs to happen before the next reduction, what the first moves are, realistic timeline. A sequence, not a calendar.

Stability Targets — specific, observable signals that indicate readiness for the next reduction. Sleep hours, morning baseline, inter-dose window. Concrete markers, not vague advice.

Next Step — whether continued support makes sense and when.

The written plan is yours. Take it to your prescribing provider. Use it as the framework for your next reduction conversation.

Plan Review — $160